Biotech

top of page

WSE_logo_artwork-rgb_outline_dark green.png

Worthy Endeavor: Vivos Closes $12 Million Stock Deal as Funding Pressure Persists

Worthy Endeavor: Vivos Closes $12 Million Stock Deal as Funding Pressure Persists

Worthy Endeavor: Vivos Closes $12 Million Stock Deal as Funding Pressure Persists

2 days ago1 min read

Ultragenyx’s $203 Million Voucher Deal Offers a Funding Boost

Ultragenyx’s $203 Million Voucher Deal Offers a Funding Boost

Ultragenyx’s $203 Million Voucher Deal Offers a Funding Boost

6 days ago1 min read

WSE’s Pick of the Week: Quantum-Si Is One Step Away From a Major Breakthrough

WSE’s Pick of the Week: Quantum-Si Is One Step Away From a Major Breakthrough

WSE’s Pick of the Week: Quantum-Si Is One Step Away From a Major Breakthrough

Worthy Endeavors

6 days ago2 min read

Liquidia Pays $380.7 Million to Clear YUTREPIA’s Legal Path

Liquidia Pays $380.7 Million to Clear YUTREPIA’s Legal Path

Liquidia Pays $380.7 Million to Clear YUTREPIA’s Legal Path

Oct 151 min read

Worthy Endeavor: NervGen Begins Pivotal Spinal Cord Injury Trial

Worthy Endeavor: NervGen Begins Pivotal Spinal Cord Injury Trial

Worthy Endeavor: NervGen Begins Pivotal Spinal Cord Injury Trial

Worthy Endeavors

Oct 131 min read

Syndax Trial Failure Narrows Its Growth Outlook

Syndax Trial Failure Narrows Its Growth Outlook

Syndax Trial Failure Narrows Its Growth Outlook

Oct 131 min read

Merck’s Keytruda Expansion Hits a European Roadblock

Merck’s Keytruda Expansion Hits a European Roadblock

Merck’s Keytruda Expansion Hits a European Roadblock

Oct 131 min read

Nvidia-Backed Drug Developer Targets $159 Million IPO

Nvidia-Backed Drug Developer Targets $159 Million IPO

Nvidia-Backed Drug Developer Targets $159 Million IPO

Oct 131 min read

Genmab Rises as AbbVie Cancer Trial Opens Growth Opportunity

Genmab Rises as AbbVie Cancer Trial Opens Growth Opportunity

Genmab Rises as AbbVie Cancer Trial Opens Growth Opportunity

Oct 71 min read

Worthy Endeavor Spotlight: Quantum BioPharma Ltd. (NASDAQ: QNTM)

Worthy Endeavor Spotlight: Quantum BioPharma Ltd. (NASDAQ: QNTM)

Worthy Endeavor Spotlight: Quantum BioPharma Ltd. (NASDAQ: QNTM)

Worthy Endeavors

Oct 71 min read

Novartis Makes $7.8 Billion Bet on the Next Wave of RNA Drugs

Novartis Makes $7.8 Billion Bet on the Next Wave of RNA Drugs

Novartis Makes $7.8 Billion Bet on the Next Wave of RNA Drugs

Oct 51 min read

ADARx Raises $446 Million as Biotech IPOs Regain Momentum

ADARx Raises $446 Million as Biotech IPOs Regain Momentum

ADARx Raises $446 Million as Biotech IPOs Regain Momentum

Sep 281 min read

Genentech Makes a $1.5 Billion Bet on AI-Designed Cancer Drugs

Genentech Makes a $1.5 Billion Bet on AI-Designed Cancer Drugs

Genentech Makes a $1.5 Billion Bet on AI-Designed Cancer Drugs

Sep 281 min read

Grail’s Cancer Test Faces Its Most Important Question Yet

Grail’s Cancer Test Faces Its Most Important Question Yet

Grail’s Cancer Test Faces Its Most Important Question Yet

Sep 241 min read

I LOVE YOU

I LOVE YOU

I LOVE YOU

Sep 181 min read

2

bottom of page